BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2293625)

  • 1. Effect of doxorubicin on local recurrence following marginal resection in the MGH-OGS murine model.
    Bell RS; O'Connor G; Bell DF; Jacob J
    J Orthop Res; 1990 Jan; 8(1):105-18. PubMed ID: 2293625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of doxorubicin on local recurrence following marginal resection in the MGH-OGS murine osteosarcoma.
    Bell RS; O'Connor G; Bell DF; Jacob J
    Chir Organi Mov; 1990; 75(1 Suppl):67-73. PubMed ID: 2249562
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy and surgery in a murine osteosarcoma.
    Bell RS; Jacobs J
    J Orthop Res; 1992 Sep; 10(5):720-8. PubMed ID: 1500984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of chemotherapy and surgery in a murine osteosarcoma model.
    Bell RS; Roth YF; Gebhardt MC; Bell DF; Rosenberg AE; Mankin HJ; Suit HD
    Cancer Res; 1988 Oct; 48(19):5533-8. PubMed ID: 3166399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance-1 gene expression does not increase during tumor progression in the MGH-OGS murine osteosarcoma tumor model.
    Trammell RA; Johnson CB; Barker JR; Bell RS; Allan DG
    J Orthop Res; 2000 May; 18(3):449-55. PubMed ID: 10937633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
    Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
    Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus.
    Gupta GR; Yasko AW; Lewis VO; Cannon CP; Raymond AK; Patel S; Lin PP
    Cancer; 2009 Aug; 115(16):3767-73. PubMed ID: 19517468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of interstitial laser coagulation and doxorubicin in a murine tumor recurrence model of solitary colorectal liver metastasis.
    Veenendaal LM; van Hillegersberg R; Smakman N; van der Bilt JD; van Diest PJ; Kranenburg O; Borel Rinkes IH
    Ann Surg Oncol; 2006 Feb; 13(2):168-75. PubMed ID: 16424982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
    Trovik CS;
    Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant androgen withdrawal therapy decreases local recurrence rates following tumor excision in the Shionogi tumor model.
    Gleave ME; Sato N; Goldenberg SL; Stothers L; Bruchovsky N; Sullivan LD
    J Urol; 1997 May; 157(5):1727-30. PubMed ID: 9112514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
    Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
    Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
    Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for local control of osteosarcoma.
    DeLaney TF; Park L; Goldberg SI; Hug EB; Liebsch NJ; Munzenrider JE; Suit HD
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):492-8. PubMed ID: 15667972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of 1 alpha hydroxyvitamin D3 inhibits tumor growth and metastasis of a murine osteosarcoma model.
    Hara K; Kusuzaki K; Takeshita H; Kuzuhara A; Tsuji Y; Ashihara T; Hirasawa Y
    Anticancer Res; 2001; 21(1A):321-4. PubMed ID: 11299756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteosarcoma chemotherapy effect: a prognostic factor.
    Raymond AK; Chawla SP; Carrasco CH; Ayala AG; Fanning CV; Grice B; Armen T; Plager C; Papadopoulos NE; Edeiken J
    Semin Diagn Pathol; 1987 Aug; 4(3):212-36. PubMed ID: 3313606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
    Bacci G; Mercuri M; Briccoli A; Ferrari S; Bertoni F; Donati D; Monti C; Zanoni A; Forni C; Manfrini M
    Cancer; 1997 Jan; 79(2):245-54. PubMed ID: 9010097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.